Explore Products
Tumor Cell Lines

DL-40

  • BSL

    1

  • 301
Ki-1-positive human T-cell lymphoma cell line. Leukemic phase of non-Hodgkin's lymphoma. Exhibits Ki-1 antigen (CD30), E+, CD2+, CD4+, CD45+, Ia+, rearranged T-cell receptor beta, acid phosphatase. Negative for CD15, peroxidase, EBNA and HTLV-1 antigen.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Product Code

DL40

Species

Human

Cat.No

ABC-TC0210

Product Category Tumor Cell Lines
Size/Quantity

1 vial

Cell Type

Lymphoid

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Disease

Anaplastic Large Cell Lymphoma

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Human Leukemia Cell Lines

Description

DL-40DL-40 is a human Ki-1-positive T-cell lymphoma cell line that was originally isolated from the peripheral blood of a 64-year-old female patient with aggressive large cell lymphoma. DL-40 exhibits lymphoblast morphology and suspension culture properties with or without forming clumps, featuring abundant cytoplasm encompassing large, round, or multiple nuclei that exhibited a positive reaction to acid phosphatase. DL-40 expresses a Ki-1 antigen (CD30), E+, CD2+, CD4+, CD45+, and Ia+; it’s positive for acid phosphatase and negative for peroxidase, Epstein-Barr virus nuclear antigen, and HTLV-1 antigen. The karyotype of DL-40s shows complex hyperdiploid abnormalities.

View Product Image

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • With its unique attributes, the DL-40 cell line assumes a pivotal role in unraveling the intricacies of Ki-1-positive non-Hodgkin’s lymphoma biology. Serving as a robust in vitro model, it facilitates the exploration of key determinants influencing tumor survival within the context of anaplastic large-cell lymphoma. Moreover, its utility extends to investigating the mechanisms underlying lymph node metastasis and propels advancements in therapeutic modalities, ultimately contributing to the targeted development of innovative drugs.

Inquiring DL-40

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button